Hormones of hypothalamic-pituitary-thyroid axis are significant regulators of synthesis and secretion of vitamin K-dependent plasma coagulation factors

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 1, 2011, Pages 21-26

  Negrev, Negrin N ^a   Tashev, R ^b   Radev, R ^a   Anogeianaki, A ^c   Ivanova, M ^a  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Clotting factors ii, vii, ix, x Antigen levels; Hypothalamic pituitary thyroid axis

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; LIOTHYRONINE; PROTHROMBIN; PROTIRELIN; THYROTROPIN; THYROXINE; VITAMIN K GROUP; HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; NONHUMAN; RAT; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PROTEIN SYNTHESIS; SECRETION; THYROID GLAND; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; BLOOD COAGULATION FACTORS; HORMONES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PROTEIN BIOSYNTHESIS; RATS; RATS, WISTAR; THYROID GLAND; VITAMIN K;

EID: 79955653593     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 2007; 92:3006-12. (Pubitemid 47236363)
2. Squizzato A, Romualdi E, Buller HR, Gerdes VE. Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab 2007; 92:2415-20. (Pubitemid 47037335)
3. Squizzato A., Gerdes VE, Brandjes DP, Büller HR, Stam J. Thyroid diseases and cerebrovascular disease. Stroke 2005; 36:2302-10. (Pubitemid 41429267)
4. Marongiu F, Cauli C, Mariotti S. Thyroid. Hemostasis and thrombosis. J Endocrinol Invest 2004; 27:1065-71.
5. Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS, Lin KH. Thyroid hormone receptor dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 2004; 145:2804-14. (Pubitemid 38686230)
6. Gursoy A, Ozduman Cin M, Kamel N, Gullu S. Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy. Int J Clin Pract 2006; 60:655-9. (Pubitemid 43811642)
7. Wahrenberg H, Wennlund A, Hoffstedt J. Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism. Eur J Endocrinol 2002; 146:607-11. (Pubitemid 34552492)
8. Stassen JM, Arnout J, Deckmyn H. The hemostatic system. Curr Med Chem 2004; 11:2245-60. (Pubitemid 39172347)
9. Guldiken S, Demir M, Turgut B, Altun BU, Arikan E, Kara M. Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocr J 2005; 52:363-7. (Pubitemid 41003528)
10. Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ, Ozden M, Duman C. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2003; 13:971-7. (Pubitemid 37351881)
11. Chadarevian R, Jublanc C, Bruckert E, Giral P, Ankri A, Leenhardt L, Chapman J, Turpin G. Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism. J Endocrinol Invest 2005; 28:398-404. (Pubitemid 43162733)
12. Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol 2005; 152:355-61. (Pubitemid 40439487)
13. Erem C, Ersoz HO, Karti SS, Ukinç K, Hacihasanoglu A, Deger O, Telatar M. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 2002; 25:345-50. (Pubitemid 34436130)
14. Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf) 2006; 64:323-9.
15. Gallistl S, Cvirn G, Leschnik B, Muntean W. Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA. Blood Coagul Fibrinolysis 2002; 13:653-5. (Pubitemid 35253362)
16. Colman RW, Hirsh J, Marder VJ, Clowes AW. Overview of Coagulation, Fibrinolysis, and Their Regulation. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Eds, Lippincott Williams & Wilkins. Philadelphia 2006; p. 17.
17. Lind SE, Marks PW, Ewenstein BM, Handin RI, Lux SE, Stossel TP. Hemostatic System. In: Blood: Principles and Practice of Hematology, eds. Lippincott Williams & Wilkins. Philadelphia 2003; p. 959.
18. Shim YS, Park CO, Hyun DK, Park HC, Yoon SH. What are the causative factors for a slow, progressive enlargement of a chronic subdural hematoma? Yonsei Med J 2007; 48:210-7. (Pubitemid 46711750)
19. Carvalho A, Schiffman FJ. Hemostasis and Thrombosis. In: Hematologic Pathophysiology. Ed. Lippincott-Raven, Philadelphia 1998; p. 161.
20. Girolami A, Scandellari R, Scapin M, Vettore S. Congenital bleeding disorders of the vitamin K-dependent clotting factors. Vitam Horm 2008; 78:281-374.
21. Bandyopadhyay PK. Vitamin K-dependent gamma-glutamylcarboxylation: an ancient posttranslational modification. Vitam Horm 2008; 78:157-84.
22. Sakaguchi Y, Suga S, Oshida K, Miyamoto-Kuramitsu K, Ueda K, Miyamoto Y. Anticoagulant effect of sodium dehydroacetate (DHA-S) in rats. J Appl Toxicol 2008; 28:524-9. (Pubitemid 351716537)
23. Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz HO. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. Endocrine 2009; 35:75-80.
24. Franchini M. Tiroide ed emostasi. Recenti Prog Med 2006; 97:267-71. (Pubitemid 43951912)
25. Venditti P, Di Meo S. Thyroid hormone-induced oxidative stress. Cell Mol Life Sci 2006; 63:414-34.
26. Vieira CS, Ferriani RA, Garcia AA, Pintao MC, Azevedo GD, Gomes MK, Silva-de-Sá MF. Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade. Hum Reprod 2007; 22:2196-201. (Pubitemid 47241866)
27. Souto JC, Almasy L, Blangero J, Stone W, Borrell M, Urrutia T, Mateo J, Fontcuberta J. Genetic regulation of plasma levels of vitamin K-dependent proteins involved in hematostatis: results from the GAIT Project. Genetic Analysis of Idiopathic Thrombophilia. Thromb Haemost 2001; 85:88-92. (Pubitemid 32050948)